Education
About Us
Working with TipRanks
Follow Us
Apyx Medical (APYX)
NASDAQ:APYX
APYX Stock Chart & Stats
$3.13
-$0.11(-6.43%)
At close: 4:00 PM EST
$3.13
-$0.11(-6.43%)
Day’s Range― - ―
52-Week Range$0.76 - $4.44
Previous CloseN/A
Volume28.06K
Average Volume (3M)120.72K
Market Cap
$143.19M
Enterprise Value$101.51M
Total Cash (Recent Filing)$25.14M
Total Debt (Recent Filing)$39.21M
Price to Earnings (P/E)―
Beta2.03
Next Earnings
Mar 12, 2026EPS Estimate
-0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding41,029,620
10 Day Avg. Volume65,017
30 Day Avg. Volume120,723
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)3.95
Price to Sales (P/S)1.17
P/FCF Ratio-2.99
Enterprise Value/Market Cap0.71
Enterprise Value/Revenue2.12
Enterprise Value/Gross Profit3.38
Enterprise Value/Ebitda-12.88
Forecast
1Y Price Target
$6.00Price Target Upside91.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)-0.31
Revenue Forecast (FY)$51.19M
Bulls Say, Bears Say
Bulls Say
Market ExpansionApyx moved into a full nationwide commercial rollout in September following a successful soft launch this summer with 'overwhelmingly positive' feedback from early adopters.
Market OpportunityApyx estimates the market in which it operates represents a $10B+ opportunity across handpiece and generator sales.
Product ApprovalThe company's Renuvion technology is the only approved device for treatment of loose skin post liposuction and contracting subcutaneous soft tissue anywhere on the body.
Bears Say
Commercialization ChallengesRisks that could prevent APYX shares from achieving our price target include slower-than-expected commercialization of AYON.
Macroeconomic FactorsRisks that could prevent APYX shares from achieving our price target include macroeconomic headwinds impacting the cash-pay aesthetics market.
Regulatory RisksRisks that could prevent APYX shares from achieving our price target include regulatory setbacks.
Apyx Medical News
APYX FAQ
What was Apyx Medical’s price range in the past 12 months?
Apyx Medical lowest stock price was $0.76 and its highest was $4.44 in the past 12 months.
What is Apyx Medical’s market cap?
Apyx Medical’s market cap is $143.19M.
When is Apyx Medical’s upcoming earnings report date?
Apyx Medical’s upcoming earnings report date is Mar 12, 2026 which is in 79 days.
How were Apyx Medical’s earnings last quarter?
Apyx Medical released its earnings results on Nov 06, 2025. The company reported -$0.05 earnings per share for the quarter, beating the consensus estimate of -$0.102 by $0.052.
Is Apyx Medical overvalued?
According to Wall Street analysts Apyx Medical’s price is currently Undervalued.
Does Apyx Medical pay dividends?
Apyx Medical does not currently pay dividends.
What is Apyx Medical’s EPS estimate?
Apyx Medical’s EPS estimate is -0.06.
How many shares outstanding does Apyx Medical have?
Apyx Medical has 41,029,620 shares outstanding.
What happened to Apyx Medical’s price movement after its last earnings report?
Apyx Medical reported an EPS of -$0.05 in its last earnings report, beating expectations of -$0.102. Following the earnings report the stock price went up 6.688%.
Which hedge fund is a major shareholder of Apyx Medical?
Currently, no hedge funds are holding shares in APYX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Apyx Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.00 (91.69% Upside)
$6.00 (91.69% Upside)
Hedge Fund Trend
Decreased
By 70.8K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
129.93%
12-Months-Change
Fundamentals
Return on Equity
-172.18%
Trailing 12-Months
Asset Growth
-5.53%
Trailing 12-Months
Company Description
Apyx Medical
Apyx Medical Corporation (NASDAQ: APYX) is a medical technology company specializing in the development and commercialization of innovative surgical products. The company focuses on two main sectors: surgical energy and cosmetic dermatology. Apyx Medical's core product offerings include the Renuvion® technology, which utilizes helium plasma for skin rejuvenation and various surgical applications, as well as a range of devices designed for energy-based surgical procedures aimed at improving patient outcomes.
APYX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong focus on the successful launch and market acceptance of the AYON Body Contouring System, with substantial revenue growth in the Surgical Aesthetics segment. Despite declines in OEM revenue and international sales, the company's strategic focus on AYON and improved financial health contribute to a positive outlook.View all APYX earnings summariesAPYX Stock 12 Month Forecast
Average Price Target
$6.00
▲(91.69% Upside)
Technical Analysis
Ownership Overview
1.46%
Insiders
8.24% Mutual Funds
28.99% Other Institutional Investors
57.92% Public Companies and
Individual Investors